September 20, 2018
Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. The proceeds of the financing will be used to accelerate commercial expansion and clinical development of its DTRAX® line of cervical fusion instruments designed to help patients suffering from advanced cervical spine conditions.
Read MoreMay 22, 2018
Providence Medical Technology, Inc. today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its DTRAX® Spinal System to be specifically indicated for use in posterior cervical fusion in patients with cervical degenerative disc disease.
January 8, 2018
Jeremy Laynor joins Providence as Vice President of US sales. Two new studies published in the Journal of Craniovertebral Junction and Spine further demonstrate the clinical benefits of Providence's unique cervical fusion technology.
September 27, 2017
Announces FDA Regulatory Clearance for ALLY® Posterior Fixation System.
July 10, 2017
Multiple independent studies demonstrate the results of Providence's tissue-sparing posterior cervical fusion technology.
May 10, 2017
Proceeds to further commercialize and expand distribution of cervical fusion technology.
March 29, 2017
Scott Lynch appointed Vice President of Global Marketing and Michael Scott Vice President of International.
January 9, 2017
Mr. Curhan brings extensive experience managing high-performing teams and executing acquisition and public offering transactions.
December 20, 2016
Global Healthcare Investor MVM Life Science Partners Leads Round.
December 13, 2016
Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the publication of “Novel instrumentation and technique for tissue sparing posterior cervical fusion” in the Journal of Clinical Neuroscience by Bruce McCormack, MD and Raman Dhawan, MD.
Our Mission is to establish Circumferential Cervical Fusion (CCF) as the standard of care for high-risk patients.
